Skinlycious Glow Exfoliant

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the treatment of acne. It aids in the prevention of the development of new acne blemishes.

Dosage and Administration

Healthcare professionals are advised to ensure thorough cleansing of the skin prior to the application of this product.

For the treatment of acne, the solution should be applied using a wet cotton bud or pad, covering the entire affected area with a thin layer. This application can be performed one to three times daily, depending on the severity of the condition and as directed by a physician. It is suitable for use on both facial and body acne.

Initial treatment should begin with one application per day, with the frequency gradually increased to two or three times daily as needed. Should the patient experience bothersome dryness or peeling, it is recommended to reduce the application frequency to once daily or every other day.

For use as a full face exfoliant, a wet cotton pad should be used to apply a thin layer of the solution in the evening only, covering the entire face. There is no need to rinse off the product after application. Once the skin condition shows improvement, the frequency of application should be reduced to no more than 3-5 times per week, maintaining the evening-only application schedule.

Contraindications

There are no contraindications associated with the use of this product. It is not classified as a controlled substance, and there are no identified risks of abuse, misuse, or dependence.

Warnings and Precautions

For external use only. This product is contraindicated in individuals who are pregnant, children under 3 years of age, or those with a known allergy to salicylates.

When utilizing this product, healthcare professionals should advise patients that the likelihood of skin irritation and dryness increases if another topical acne medication is used concurrently. It is recommended that only one topical acne medication be applied at a time to minimize the risk of irritation. Patients should also be cautioned to avoid unnecessary sun exposure and to apply a broad-spectrum sunscreen to protect the skin. Care should be taken to prevent contact with the eyes, lips, and mouth.

First-time users may experience a tingling sensation and visible peeling of the skin. These effects are typically transient and may diminish with continued use. However, if irritation becomes severe, patients should be instructed to discontinue use and consult a healthcare provider.

In the event of accidental ingestion, immediate medical assistance should be sought, or the local Poison Control Center should be contacted without delay.

Side Effects

Patients should be aware that this product is for external use only and should not be used by individuals who are pregnant, children under 3 years of age, or those with an allergy to salicylates.

During the use of this product, skin irritation and dryness may occur, particularly if another topical acne medication is used concurrently. It is recommended that patients avoid unnecessary sun exposure and utilize sunscreen to mitigate potential adverse effects. Additionally, contact with the eyes, lips, and mouth should be avoided to prevent irritation.

First-time users may experience a tingling sensation and visible peeling of the skin. These sensations are expected to diminish with frequent use. However, if irritation becomes severe, patients are advised to discontinue use and consult a healthcare professional.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Skinlycious Glow Exfoliant (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 3 years of age should not use this medication. There are no specific dosage recommendations or safety data available for this age group. Caution is advised when considering treatment options for younger children, and healthcare professionals should evaluate the risks and benefits before prescribing.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

Pregnant patients should not use this medication. The potential risks associated with the use of this drug during pregnancy have not been established, and its safety profile in pregnant women remains unclear. Therefore, it is crucial for healthcare providers to advise women of childbearing potential to avoid this medication if they are pregnant or planning to become pregnant.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or any lactation considerations. Healthcare professionals should exercise caution and consider the potential risks and benefits when prescribing this medication to lactating mothers. Further research may be necessary to fully understand the implications for breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant regarding the potential for overdose with this medication. In cases where an overdose is suspected, immediate medical attention should be sought.

Healthcare providers are advised to monitor patients closely for any signs or symptoms that may indicate an overdose. These may include, but are not limited to, increased severity of known side effects, altered mental status, or any unusual physiological responses.

Management of an overdose should be guided by the clinical presentation of the patient. Supportive care is paramount, and symptomatic treatment should be initiated as necessary. Healthcare professionals should also consider contacting a poison control center for additional guidance on the management of overdose cases.

Documentation of the incident, including the amount ingested and the time of exposure, is crucial for effective treatment and follow-up care. Continuous monitoring of the patient's vital signs and overall condition is recommended until they are stabilized.

Nonclinical Toxicology

The use of this product is contraindicated in pregnant individuals due to potential teratogenic effects. No non-teratogenic effects have been specified in the available data. Additionally, there are no details provided regarding nonclinical toxicology or animal pharmacology and toxicology.

Postmarketing Experience

No postmarketing experience details are provided in the insert.

Patient Counseling

Healthcare providers should advise patients that in the event of accidental ingestion, it is crucial to seek medical assistance immediately or contact a Poison Control Center. This prompt action is essential to ensure the safety and well-being of the patient.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product in a cool, dry place, ensuring it is kept away from direct sunlight to maintain its integrity and efficacy. Proper storage conditions are crucial for preserving the quality of the product throughout its shelf life.

Additional Clinical Information

The product is administered topically for the treatment of acne, utilizing a wet cotton bud or pad to apply a thin layer over the entire affected area one to three times daily. It is suitable for both facial and body acne. To mitigate the risk of excessive skin drying, patients are advised to start with one application daily, gradually increasing to two or three times daily as tolerated or directed by a clinician. Should bothersome dryness or peeling occur, patients should reduce the frequency of application to once a day or every other day.

For use as a full face exfoliant, a wet cotton pad should be used to apply a thin layer of the solution in the evening only, without rinsing off. Once the skin condition improves, the frequency of application should be reduced to no more than 3-5 times a week in the evening.

Drug Information (PDF)

This file contains official product information for Skinlycious Glow Exfoliant, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)